Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic Stroke
NCT05743101Not yet recruiting
- Start
- May 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of levofloxacin in ischemic stroke (2 arms). Primary endpoint: National Institute of Health stroke scale at 3 days. Planned start May 2025; status: not yet recruiting.
02
Drugs
levofloxacin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05743101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05743101.